Tempus In Brief This Week: Caris Life Sciences, Psomagen, Tempus, CareDx, HTG Molecular, Epigenomics, More News items for the week of Nov 8, 2021. Cedars-Sinai, Tempus Partner on Molecular Database Initiative The partners launched the Molecular Twin initiative to collect cancer patients' DNA, RNA, and protein information and use it to inform treatment and advance research. Tempus Submits PMA Application for Tumor Profiling Assay to FDA The firm has submitted companion diagnostic and tumor profiling, and MSI status claims using DNA from FFPE tumor tissue and matched normal specimens. Rain Therapeutics, Tempus Partner to Identify Patients with MDM2-Amplified Tumors for Basket Trial Tempus will provide centralized DNA and RNA tumor sequencing to help Rain enroll patients in a Phase II trial for its MDM2 inhibitor. New Products Posted to GenomeWeb: Tempus, Canopy Biosciences, Lonza, More Mar 3, 2021 Tempus, Texas Oncology Subsidiary Form Data-Focused Precision Oncology Partnership Feb 25, 2021 Kronos Bio Doses First Patient in CDK9 Inhibitor Trial With Tempus Performing Sequencing Feb 12, 2021 New Products Posted to GenomeWeb: Tempus, Active Motif, Immudex, Zymo Research, More Jan 27, 2021 Tempus, Bristol Myers Squibb Expand Cancer Biomarker Alliance Jan 13, 2021 Tempus, A2 Biotherapeutics Partner to Develop CDx for Therapy Targeting Loss of Heterozygosity Jan 12, 2021 JP Morgan Healthcare Conference 2021, Day 1: Roche, Seer, 10x, Guardant, Hologic, Thermo Fisher Dec 14, 2020 Hummingbird Biosciences, Tempus Partner to ID Cancer Patients for Anti-HER3 Treatment Trial Dec 10, 2020 Tempus Raises $200M in Series G2, Inks Oncology Testing Collaboration With Bayer Dec 9, 2020 Nonprofit Friends of Cancer Research Launches Public-Private HRD Harmonization Project Nov 24, 2020 Tempus Gets CE Mark for xT Tumor Sequencing Assay Nov 23, 2020 Novellus, Tempus Partner to Enroll Patients in BRAF Inhibitor Clinical Trial Program Nov 16, 2020 Tempus, Yale School of Public Health Partner to Update Saliva-Based Coronavirus Test Nov 2, 2020 Tempus, Janssen R&D Collaborate on Oncology Clinical Trial Matching Oct 14, 2020 Tempus Enters Infectious Disease Market With Large-Scale COVID-19 Testing, Data Initiative Premium Oct 13, 2020 Pancreatic Cancer Action Network Launches Adaptive Clinical Trial Platform Oct 2, 2020 Tempus, Alimetrix Molecular Coronavirus Tests Get FDA Emergency Use Authorization Sep 16, 2020 LabCorp's Covance Joins Tempus TIME Trial Program Mar 16, 2020 With $100M in New Funding, Tempus Targets Diseases Beyond Cancer Premium Mar 13, 2020 Tempus Closes $100M Series G Round Feb 26, 2020 Congressional Caucus Working to Raise Personalized Medicine Awareness Among Legislators Premium Load More Breaking News New Approach Identifies Candidate Causal Variants for Neuropsychiatric, Neurodevelopmental Conditions People in the News: Baylor's Thomas Caskey Dies; New Appointments at UK Biobank, CS Genetics, More In Brief This Week: Pathogenomix, Uniogen, Genetic Technologies, DnaNudge, Gravity Diagnostics, More New Products Posted to GenomeWeb: Biodesix, Curio Genomics, Akoya Biosciences, More NIH Earmarks $170M for All of Us Program's Personalized Nutrition Study Taiwanese Firm's IP Asserted in Suit Against Pacific Biosciences Found Partially Unpatentable The Scan Omicron's Sewage Path The New York Times writes that testing sewage is helping public health officials track Omicron. IBM Sells Part of Watson Health The Wall Street Journal reports IBM is selling part of its Watson Health business to an investment firm. Identifying the Right Whales The Boston Globe writes that genetic testing has helped identify North American right whales and find that weaning can take place earlier than thought. Science Papers on Approach to Quickly Sort Single Cells, Alternative Splicing in Cancer In Science this week: high-speed sorting of single cells using fluorescence imaging, and more.